Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Navarro

Showing results (421-430 of 444) with videos related to

Pageof 45
Sort By:
Bone Marrow Transplantation|May 7, 2026
Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committeeRoser Velasco, Martin Schmidt-Hieber, Olaf Penack, et al.
Bone Marrow Transplantation|November 3, 2023
Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapyAna Benzaquén, Estela Giménez, Gloria Iacoboni, et al.
Journal of Medical Virology|March 13, 2026
Unveiling CMV Risk Signatures After Allogeneic Stem Cell Transplantation Through Machine Learning Approaches: A Multicenter Analysis From the GETH-TCEstela Giménez, Pablo Rodriguez-Belenguer, Carlos Solano, et al.
Viruses|October 28, 2023
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy RecipientsJosé Luis Piñana, Inmaculada Heras, Tommaso Francesco Aiello, et al.
Bone Marrow Transplantation|March 1, 2023
SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccinationJosé Luis Piñana, Rodrigo Martino, Lourdes Vazquez, et al.
Journal of Hematology & Oncology|May 7, 2022
SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disordersJosé Luis Piñana, Lucia López-Corral, Rodrigo Martino, et al.
Molecular Ecology Resources|November 26, 2025
Development of High-Throughput Genomic Resources to Inform White-Tailed Deer Population and Disease ManagementDavid Navarro, Emily K Latch, Anaïs K Tallon, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|September 20, 2011
GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patientsJulian de la Torre-Cisneros, M Carmen Fariñas, Juan José Castón, et al.
Plos One|February 6, 2023
The role of the T-cell mediated immune response to Cytomegalovirus infection in intrauterine transmissionMaría Soriano-Ramos, Estrella Esquivel-De la Fuente, Eliseo Albert Vicent, et al.
Leukemia & Lymphoma|October 20, 2021
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patientsJosé Luis Piñana, Lourdes Vázquez, Rodrigo Martino, et al.
Pageof 45

Showing results (421-430 of 444) with videos related to

Sort By:
Pageof 45
Bone Marrow Transplantation|May 7, 2026
Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committeeRoser Velasco, Martin Schmidt-Hieber, Olaf Penack, et al.
Bone Marrow Transplantation|November 3, 2023
Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapyAna Benzaquén, Estela Giménez, Gloria Iacoboni, et al.
Journal of Medical Virology|March 13, 2026
Unveiling CMV Risk Signatures After Allogeneic Stem Cell Transplantation Through Machine Learning Approaches: A Multicenter Analysis From the GETH-TCEstela Giménez, Pablo Rodriguez-Belenguer, Carlos Solano, et al.
Viruses|October 28, 2023
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy RecipientsJosé Luis Piñana, Inmaculada Heras, Tommaso Francesco Aiello, et al.
Bone Marrow Transplantation|March 1, 2023
SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccinationJosé Luis Piñana, Rodrigo Martino, Lourdes Vazquez, et al.
Journal of Hematology & Oncology|May 7, 2022
SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disordersJosé Luis Piñana, Lucia López-Corral, Rodrigo Martino, et al.
Molecular Ecology Resources|November 26, 2025
Development of High-Throughput Genomic Resources to Inform White-Tailed Deer Population and Disease ManagementDavid Navarro, Emily K Latch, Anaïs K Tallon, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|September 20, 2011
GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patientsJulian de la Torre-Cisneros, M Carmen Fariñas, Juan José Castón, et al.
Plos One|February 6, 2023
The role of the T-cell mediated immune response to Cytomegalovirus infection in intrauterine transmissionMaría Soriano-Ramos, Estrella Esquivel-De la Fuente, Eliseo Albert Vicent, et al.
Leukemia & Lymphoma|October 20, 2021
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patientsJosé Luis Piñana, Lourdes Vázquez, Rodrigo Martino, et al.
Pageof 45